Step 1 topics → Biochemistry → Genetic Terms and Concepts

Genetic Terms and Concepts

USMLE Step 1 trap: Conflates penetrance (who is affected) with expressivity (how severely they are affected). Penetrance is the proportion of individuals with a genotype who show any phenotype (all-or-none); expressivity describes the degree of phenotypic variation among those who do express the trait.

Genetic terms and concepts is one of those topics where students feel confident going in and then get burned by subtle distinctions on exam day. The vocabulary — penetrance, expressivity, anticipation, pleiotropy, locus heterogeneity, dominant negative, haploinsufficiency, LOH, uniparental disomy — looks familiar from lecture, but USMLE Step 1 doesn't just ask you to define these terms. It embeds them in clinical vignettes and asks you to identify which mechanism explains the observed pattern, or why two siblings with the same mutation have different outcomes. That's where the traps are.

The trickiest part of this topic is that several terms are genuinely easy to conflate because they're related — penetrance and expressivity both involve genotype-phenotype relationships, and dominant negative and haploinsufficiency both explain why heterozygotes get sick. But the exam absolutely distinguishes between them. Penetrance is a population-level, all-or-none concept (what fraction of people with the genotype show any phenotype at all), while expressivity is about degree of severity among those who do express. Conflating these two is the single most common error students make here. Similarly, dominant negative and haploinsufficiency sound like two ways of saying the same thing, but the mechanism is fundamentally different: one is about quantity, the other is about active interference.

Uniparental disomy and mosaicism are the clinical correlate traps. Students often assume UPD is always pathological, but disease only emerges when the duplicated chromosome carries imprinted genes — and the clinical syndrome depends on which parent's copy you got two of. Prader-Willi vs. Angelman is the canonical pair USMLE Step 1 loves to test here. Getting these distinctions locked down cold is what separates a 240+ performance on this section from a guessing game.

From real student decks
89%have cards covering this topic
73%have mature cards
1median lapses in 14 days

Well-covered in most decks — the challenge is retention, not exposure.

Common misconceptions

Common mistake
Wrong: Penetrance and expressivity both describe how severely a disease manifests in an individual.
Right: Penetrance is the proportion of individuals with a genotype who show any phenotype (all-or-none); expressivity describes the degree of phenotypic variation among those who do express the trait.
Penetrance operates at the population level and is binary: either an individual with a given genotype shows the phenotype or they don't. If 80% of people with a mutation develop disease, that's 80% penetrance — the other 20% show nothing at all. Expressivity only applies to those who do express the trait, and it describes how much variation exists in the severity or pattern of that expression. Think of it this way: penetrance tells you who shows up to the party; expressivity tells you how wild each person's experience at the party is. Mixing them up leads to wrong answers whenever the stem describes a family where some members are unaffected (penetrance issue) versus members who are all affected but to different degrees (expressivity issue).
Common mistake
Wrong: Dominant negative and haploinsufficiency are interchangeable mechanisms for why heterozygous loss-of-function causes disease.
Right: Haploinsufficiency means one functional allele produces insufficient protein for normal function; dominant negative means the mutant protein actively interferes with the normal protein product.
Haploinsufficiency is purely a dosage problem: one working copy of the gene simply doesn't make enough functional protein to keep things running normally. No sabotage is happening — there's just not enough product. Dominant negative is mechanistically active: the mutant protein is produced, it can still interact with the normal protein (often in a multimer or complex), and it poisons or blocks the function of the normal copy. A classic example is a mutant collagen chain that incorporates into a triple helix and destabilizes it — one bad chain wrecks the whole structure. The key distinction: haploinsufficiency is about insufficient output, dominant negative is about a mutant product that actively breaks the system.
Common mistake
Wrong: Uniparental disomy always causes disease regardless of which chromosome is involved.
Right: Uniparental disomy causes disease only when the affected chromosome carries imprinted genes; the clinical outcome depends on whether the maternal or paternal copy is duplicated (e.g., Prader-Willi vs Angelman).
Most chromosomes carry genes that are expressed from both parental copies, so having two copies from one parent is functionally fine — you still have two working copies of every gene. Disease only arises when the chromosome involved carries imprinted genes, meaning one parental copy is silenced epigenetically. If you get two copies from the parent whose copy is normally silenced, you end up with no functional expression of those genes. Chromosome 15 is the prototypical example: two paternal copies silences the maternally expressed genes → Angelman syndrome; two maternal copies silences the paternally expressed genes → Prader-Willi syndrome. The lesson is that UPD pathology is entirely dependent on which chromosome and which parental copy is duplicated.
Free Deck audit

See if your Anki deck covers this topic.

Upload your deck →
Guided session

Stuck on this? An AI tutor that probes your understanding.

Start a session →

What the exam tests

  1. Define and distinguish penetrance, expressivity, pleiotropy, anticipation, and genetic heterogeneity — the exam uses vignettes to force you to pick the right term, not just recall its definition.
  2. Explain the mechanisms behind loss of heterozygosity (LOH), dominant negative mutations, and haploinsufficiency — especially why heterozygous mutations can cause disease and which mechanism is responsible in a given scenario.
  3. Apply mosaicism and uniparental disomy to clinical cases — recognizing when UPD is pathological, which parent's copy matters, and how mosaicism produces variable phenotypes within and between individuals.

Can you avoid these mistakes?

A family has an autosomal dominant condition. The father carries the mutation and is completely unaffected; two of his three children have the disease, one severely and one mildly. What concept explains why the father is unaffected, and what concept explains the difference in severity between his two affected children?
A patient with osteogenesis imperfecta has a heterozygous mutation in COL1A1 that produces a structurally abnormal collagen chain. One normal allele is still present. Why does this single mutant allele cause severe disease — is this haploinsufficiency or dominant negative, and how do you know?
A child is diagnosed with Prader-Willi syndrome but genetic testing shows no deletion on chromosome 15. DNA methylation studies reveal two maternal copies of chromosome 15. Explain the mechanism and why two intact chromosomes still cause disease.
A woman with neurofibromatosis type 1 (NF1, autosomal dominant, tumor suppressor) develops a peripheral nerve sheath tumor. A biopsy shows loss of the remaining wild-type NF1 allele in tumor cells. What mechanism explains this finding, and what term describes the phenomenon?

Related topics

Inheritance Patterns Nucleotide and Nucleic Acid Structure DNA Replication DNA Repair Pathways Mutations and Their Consequences

See how your Anki deck covers this topic.

Upload your deck for a free audit →